XII.ay
Coronary (artery) vasculitis
Causative drugs
3
Clomipramine
I.c
I - Interstitial/parenchymal lung disease
I.c - Eosinophilic pneumonia (pulmonary infiltrates and eosinophilia) I.d I - Interstitial/parenchymal lung disease
I.d - Organizing pneumonia pattern (an area or areas of consolidation on imaging) IX.d IX - Neuromuscular / CNS involvement - Disordered breathing during sleep
IX.d - Respiratory failure from ventilatory depression (due to neuromuscular blockade/paralysis) X.a X - Systemic/Distant conditions, syndromes and reactions
X.a - DRES syndrome - DRESS-like reaction XII.d XII - Cardiovascular involvement / toxicity
XII.d - Myocarditis (can be fulminant) XII.ay XII - Cardiovascular involvement / toxicity
XII.ay - Coronary (artery) vasculitis XV.cb XV - Pathology
XV.cb - Path: Lymphocytic myocarditis XV.cc XV - Pathology
XV.cc - Path: Eosinophilic myocarditis XV.cm XV - Pathology
XV.cm - Path: Coronary vasculitis w/wo eosinophilia
I.c - Eosinophilic pneumonia (pulmonary infiltrates and eosinophilia) I.d I - Interstitial/parenchymal lung disease
I.d - Organizing pneumonia pattern (an area or areas of consolidation on imaging) IX.d IX - Neuromuscular / CNS involvement - Disordered breathing during sleep
IX.d - Respiratory failure from ventilatory depression (due to neuromuscular blockade/paralysis) X.a X - Systemic/Distant conditions, syndromes and reactions
X.a - DRES syndrome - DRESS-like reaction XII.d XII - Cardiovascular involvement / toxicity
XII.d - Myocarditis (can be fulminant) XII.ay XII - Cardiovascular involvement / toxicity
XII.ay - Coronary (artery) vasculitis XV.cb XV - Pathology
XV.cb - Path: Lymphocytic myocarditis XV.cc XV - Pathology
XV.cc - Path: Eosinophilic myocarditis XV.cm XV - Pathology
XV.cm - Path: Coronary vasculitis w/wo eosinophilia
1
Loxoprofen
I.b
I - Interstitial/parenchymal lung disease
I.b - Pneumonitis (ILD) I.c I - Interstitial/parenchymal lung disease
I.c - Eosinophilic pneumonia (pulmonary infiltrates and eosinophilia) I.d I - Interstitial/parenchymal lung disease
I.d - Organizing pneumonia pattern (an area or areas of consolidation on imaging) IV.a IV - Airway involvement
IV.a - Bronchospasm - Wheezing - Asthma XII.ay XII - Cardiovascular involvement / toxicity
XII.ay - Coronary (artery) vasculitis XII.bj XII - Cardiovascular involvement / toxicity
XII.bj - Eosinophilic coronary (peri)-arteritis XV.cm XV - Pathology
XV.cm - Path: Coronary vasculitis w/wo eosinophilia
I.b - Pneumonitis (ILD) I.c I - Interstitial/parenchymal lung disease
I.c - Eosinophilic pneumonia (pulmonary infiltrates and eosinophilia) I.d I - Interstitial/parenchymal lung disease
I.d - Organizing pneumonia pattern (an area or areas of consolidation on imaging) IV.a IV - Airway involvement
IV.a - Bronchospasm - Wheezing - Asthma XII.ay XII - Cardiovascular involvement / toxicity
XII.ay - Coronary (artery) vasculitis XII.bj XII - Cardiovascular involvement / toxicity
XII.bj - Eosinophilic coronary (peri)-arteritis XV.cm XV - Pathology
XV.cm - Path: Coronary vasculitis w/wo eosinophilia
1
Nilotinib
I.b
I - Interstitial/parenchymal lung disease
I.b - Pneumonitis (ILD) I.d I - Interstitial/parenchymal lung disease
I.d - Organizing pneumonia pattern (an area or areas of consolidation on imaging) III.a III - Pulmonary/alveolar./airway hemorrhage/bleeding
III.a - Alveolar hemorrhage (AH), diffuse AH (DAH) V.a V - Pleural and/or pericardial involvement
V.a - Pleural effusion (uni- or bilateral) (can accompany DI-LDs) V.c V - Pleural and/or pericardial involvement
V.c - Pleural thickening VI.b VI - Pulmonary vasculopathies
VI.b - Pulmonary arterial hypertension VI.d VI - Pulmonary vasculopathies
VI.d - Pulmonary vasculitis or capillaritis X.r X - Systemic/Distant conditions, syndromes and reactions
X.r - Fluid retention XII.c XII - Cardiovascular involvement / toxicity
XII.c - Pericardial effusion (w/wo tamponade) XII.k XII - Cardiovascular involvement / toxicity
XII.k - Constrictive pericarditis - Pericardial thickening XII.o XII - Cardiovascular involvement / toxicity
XII.o - Coronary artery disease (subacute, chronic) XII.ay XII - Cardiovascular involvement / toxicity
XII.ay - Coronary (artery) vasculitis XV.ao XV - Pathology
XV.ao - Path: Pleuritis, pleural fibrosis
I.b - Pneumonitis (ILD) I.d I - Interstitial/parenchymal lung disease
I.d - Organizing pneumonia pattern (an area or areas of consolidation on imaging) III.a III - Pulmonary/alveolar./airway hemorrhage/bleeding
III.a - Alveolar hemorrhage (AH), diffuse AH (DAH) V.a V - Pleural and/or pericardial involvement
V.a - Pleural effusion (uni- or bilateral) (can accompany DI-LDs) V.c V - Pleural and/or pericardial involvement
V.c - Pleural thickening VI.b VI - Pulmonary vasculopathies
VI.b - Pulmonary arterial hypertension VI.d VI - Pulmonary vasculopathies
VI.d - Pulmonary vasculitis or capillaritis X.r X - Systemic/Distant conditions, syndromes and reactions
X.r - Fluid retention XII.c XII - Cardiovascular involvement / toxicity
XII.c - Pericardial effusion (w/wo tamponade) XII.k XII - Cardiovascular involvement / toxicity
XII.k - Constrictive pericarditis - Pericardial thickening XII.o XII - Cardiovascular involvement / toxicity
XII.o - Coronary artery disease (subacute, chronic) XII.ay XII - Cardiovascular involvement / toxicity
XII.ay - Coronary (artery) vasculitis XV.ao XV - Pathology
XV.ao - Path: Pleuritis, pleural fibrosis
1